CapsoVision (NASDAQ:CV) Shares Down 6.5% – Here’s What Happened

Shares of CapsoVision, Inc. (NASDAQ:CV) fell 6.5% on Friday . The stock traded as low as $12.90 and last traded at $12.98. 11,088 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 163,197 shares. The stock had previously closed at $13.88.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Benchmark restated a “speculative buy” rating on shares of CapsoVision in a research report on Friday, November 14th. Zacks Research raised shares of CapsoVision to a “hold” rating in a research note on Wednesday, November 5th. Weiss Ratings reissued a “sell (e)” rating on shares of CapsoVision in a research note on Monday. Finally, Roth Capital set a $7.00 price objective on shares of CapsoVision in a research note on Tuesday, November 4th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, CapsoVision presently has an average rating of “Moderate Buy” and a consensus target price of $6.00.

CapsoVision Trading Down 8.6%

The company has a 50-day simple moving average of $7.18.

CapsoVision (NASDAQ:CV) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The company had revenue of $3.54 million during the quarter.

Institutional Trading of CapsoVision

An institutional investor recently bought a new position in CapsoVision stock. New York State Common Retirement Fund purchased a new stake in CapsoVision, Inc. (NASDAQ:CV) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 7,114 shares of the company’s stock, valued at approximately $34,000.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.